Treatment of chronic hepatitis B with a combination of acyclovir and alpha-lymphoblastoid interferon.
Schalm
S W
SW
Department of Internal Medicine II, Erasmus University, Rotterdam, The Netherlands.
D000212:Acyclovir / Q000008:administration & dosage / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000627:therapeutic use; D006513:Hepatitis B e Antigens / Q000097:blood; D006515:Hepatitis B virus / Q000187:drug effects / Q000502:physiology; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D008111:Liver Function Tests; D008875:Middle Aged; D016032:Randomized Controlled Trials as Topic; D014779:Virus Replication / Q000187:drug effects
D000998:Antiviral Agents; D006513:Hepatitis B e Antigens; D016898:Interferon-alpha; D000212:Acyclovir